Abstract:Lupus, Ahead of Print. BackgroundSystemic lupus erythematosus (SLE) is a complex autoimmune connective tissue disease (CTD) that is an important cause of devastating pulmonary arterial hypertension (PAH), and persistent progression of PAH can lead to right heart failure, predicting a poor prognosis for SLE patients. Right ventricular-pulmonary arterial (RV-PA) coupling with echocardiography has been demonstrated to be a noninvasive alternative method for evaluating PAH patients' predictive outcomes. Whether the ratio of right ventricular stroke volume (RVSV) to right ventricular end-systolic volume (RVESV) measured by three-dimensional echocardiography (3DE) is a new index of RV-PA coupling has not been discussed as a new predictor for the clinical outcome of systemic lupus erythematosus-associated pulmonary arterial hypertension (SLE-PAH).MethodsFrom June 2019 to February 2023, 46 consecutive patients with SLE-PAH were enrolled prospectively, and their clinical data and echocardiographs were studied and analyzed. The control group consisted of 30 healthy subjects matched for age, sex, and body surface area (BSA). The main endpoints of this study were a composite of all-cause mortality and adverse clinical events. Baseline clinical characteristics and echocardiographic assessments were analyzed.ResultsDuring a median of 24 months (IQR 18–31), 16 of 46 SLE-PAH patients (34.7%) experienced endpoint-related events. At baseline, patients who experienced mortality or adverse events had a worse WHO functional class (WHO FC) and lower anti-double-stranded DNA (dsDNA) antibody levels. The right ventricular (RV) systolic dysfunction in SLE-PAH subjects was significantly worse than that in the healthy control group, especially in SLE-PAH patients in the endpoint event group. Compared to controls, patients with SLE-PAH had a lower RVSV/RVESV ratio. In the group comparison, patients who had experienced an endpoint event had a sequentially worse ratio (1.86 (1.65–2.3) versus 1.30 (1.09–1.46) versus 0.64 (0.59-0.67), p < .001). There were statistically significant associations between the RVSV/RVESV ratio to routine RV systolic function and clinical parameters. The RVSV/RVESV ratio was negatively correlated with the WHO FC (r = −0.621, p < .001) and positively correlated with the anti-dsDNA level. The ROC curve showed that the optimal cutoff for RVSV/RVESV 0.712 was associated with more favorable long-term outcomes.ConclusionsThe 3DE-derived SV/ESV ratio as a noninvasive alternative surrogate of RV-PA coupling was an eximious indicator for identifying endpoint events in SLE-PAH patients and can provide a diagnostic basis for clinical intervention.

Applying real-time three-dimensional echocardiography with Tei index to assessment of the right heart function in patients with systemic lupus erythematous

Assessment of Real-Time Three-Dimensional Echocardiography As a Tool for Evaluating Left Atrial Volume and Function in Patients with Type 2 Diabetes Mellitus.

Evaluation of Left Atrial Function by Real-time 3-D Echocardiography in Patients with Systemic Lupus Erythematosus

[Assessment Right Atrial Function in Patients with Systemic Lupus Erythematosus by Speckle Tracking and Three-Dimensional Echocardiography].

Study on the Feasibility of Evaluating Right Ventricular Function Injury in SLE Patients by Echocardiography

Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients

Effect of Systemic Lupus Erythematosus on Right Heart Function Evaluated by Parameters Recommended by the American Society of Echocardiography

Assessment of Left Atrial Function in Patients with Chronic Heart Failure by Real-Time Three-Dimensional Echocardiography

Evaluation of Right Ventricular Regional Volume and Systolic Function in Patients with Pulmonary Arterial Hypertension Using Three-Dimensional Echocardiography

Comparative Study of Radionuclide Ventriculography and Echocardiography in Assessment of Cardiac Involvement in Patients with Systemic Lupus Erythematosus

Assessment of Coronary Flow Reserve in Systemic Lupus Erythematosus Patients by Transthoracic Echocardiography

Biventricular Tissue Tracking Demonstrating Associations Between Left Ventricular Myocardial Extracellular Volume, Pulmonary Artery Pressure, and Reduced Right Ventricular Ejection Fraction in Patients with Systemic Lupus Erythematosus Using Cardiovascular MRI

Quantitative Assessment of Right Ventricular Function in Patients with Systemic Lupus Erythematosus Using the Novel Non-invasive Pressure–Strain Loop

Evaluation of Global and Regional Right Ventricular Systolic Function in Patients with Pulmonary Hypertension by Real-Time Three-Dimensional Echocardiography

Evaluation of left atrial function by speckle tracking echocardiography in patients with systemic lupus erythematosus

Atrial and Ventricular Volumes and Ejection Functions Assessed by Real-Time Three-Dimensional Echocardiography in the Patients with Coronary Artery Disease and Cardiomyopathy

New Echocardiographic Indexes for Evaluating Cardiac Function in Idiopathic Pulmonary Arterial Hypertension Using Three-Dimensional Echocardiography

Real-time Three-Dimensional Echocardiography Assessment of Intra-Left Ventricular Systolic Synchronism in Patients with Chronic Heart Failure

Right ventricular dyssynchrony for the prediction of prognosis in patients with systemic lupus erythematosus-aaociated pulmonary arterial hypertension: a study with two-dimensional speckle tracking

Evaluation of Left Ventricular Hypertrophy in Patients with Essential Hypertension Using Real-Time Three-Dimensional Echocardiography

Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus